VOLUME 35: NO. 6 JUNE 2008

Editorials

Rheumatoid Factor, Smoking, and Disease Severity: Associations with Mortality in Rheumatoid Arthritis

N.J. Goodson, T.M. Farragher, D.P.M. Symmons.........945→RELATED ARTICLE

Occupational Exposures and Risk of Rheumatoid Arthritis: Continued Advances and Opportunities for Research

G.S. Cooper.........950→RELATED ARTICLE

Is Work Disability Associated with Systemic Lupus Erythematosus Modifiable?

S. Allaire.........953→RELATED ARTICLE

Arthritis in Indigenous Populations: A Neglected Health Disparity

E.D. Ferucci.........956 →RELATED ARTICLE

Crystal Deposition in Joints: Prevalence and Relevance for Arthritis

K.P.H. Pritzker.........958 →RELATED ARTICLE

Articles

LIGHT Induces Cell Proliferation and Inflammatory Responses of RA Synovial Fibroblasts via LTßR
   
S. Ishida, S. Yamane, S. Nakano, et al.........960

Prevalence and Significance of Anti-Peptidylarginine Deiminase 4 Antibodies in RA
   
J. Zhao, Y. Zhao, J. He, R. Jia, Z. Li.........969

A Novel Predictor of Clinical Response to MTX in Patients with RA: A Pilot Study of in Vitro T Cell Cytokine Suppression
   
N. Haroon, R. Srivastava, R. Misra, A. Aggarwal.........975

Low-dose Prednisolone in RA: Adverse Effects of Various Disease Modifying Antirheumatic Drugs
   
O.A. Malysheva, M.Wahle, U. Wagner, et al.........979

Socioeconomic and Occupational Risk Factors for RA: A Nationwide Study Based on Hospitalizations in Sweden
   
X. Li, J. Sundquist, K. Sundquist.........986→RELATED ARTICLE

Palindromic Rheumatism Is a Common Disease: Comparison of New-Onset Palindromic Rheumatism Compared to New-Onset RA in a 2-Year Cohort of Patients
   
A. Powell, P. Davis, N. Jones, A.S. Russell.........992

Anti-CCP Antibody, Smoking, Alcohol Consumption, and Disease Duration as Risk Factors for Extraarticular Manifestations in Korean Patients with RA
   
S-K. Kim, S-H. Park, I-H. Shin, J-Y. Choe.........995

Antibodies Against Mutated Citrullinated Vimentin Are a Better Predictor of Disease Activity at 24 Months in Early RA Than Antibodies Against CCP
   
L. Innala, H. Kokkonen, C. Eriksson, E. Jidell, E. Berglin, S. Rantapää-Dahlqvist.........1002

Mortality Trends in RA: The Role of Rheumatoid Factor
   
A. Gonzalez, M. Icen, H. Maradit Kremers, et al.........1009→RELATED ARTICLE

The Problem of RA Disease Activity and Remission in Clinical Practice
   
T.S. Shaver, J.D. Anderson, D.N. Weidensaul, et al.........1015

Prevalence, Risk, and Risk Factors for Oral and Ocular Dryness with Particular Emphasis on RA
   
F. Wolfe, K. Michaud.........1023

Climatic Influence on the Prevalence of Noncutaneous Disease Flare in SLE in Hong Kong
   
C-C. Szeto, H-Y. Mok, K-M. Chow, et al.........1031

The Relationship Between Neuropsychiatric, Clinical, and Laboratory Variables and Quality of Life of Chinese Patients with SLE
   
L-S. Tam, A. Wong, V.C.T. Mok, et al.........1038

Correlates of Formal Work Disability in an Urban University SLE Practice
   
T.O. Utset, S. Chohan, S.A. Booth, J.C. Laughlin, M. Kocherginsky, A. Schmitz.........1046→RELATED ARTICLE

High Prevalence of Unemployment in Patients with SLE: Association with Organ Damage and HRQOL
   
I.E.M. Bultink, F. Turkstra, B.A.C. Dijkmans, A.E. Voskuyl.........1053→RELATED ARTICLE

TCRBV20S1 and TCRBV3S1 Gene Segment Polymorphisms in SSc
   
M. Bredemeier, J.A.B. Chies, A. Wieck, et al.........1058

Therapeutic Strategy Combining IV Cyclophosphamide Followed by Oral Azathioprine to Treat Worsening Interstitial Lung Disease Associated with SSc: A Retrospective Multicenter Open-label Study
   
A. Bérezné, B. Ranque, D. Valeyre, et al.........1064

Patients with Scleroderma May Have Increased Risk of Osteoporosis. A Comparison to RA and Noninflammatory Musculoskeletal Conditions
   
S.Y. Yuen, B. Rochwerg, J. Ouimet, J.E. Pope.........1073

Development of a Core Set of Domains for Data Collection in Cohorts of Patients with AS Receiving Anti-TNF-a Therapy
   
J. Zochling, J. Sieper, D. van der Heijde, J. Braun, on behalf of the ASAS International Working Group.........1079

Bone Protective Effect of Simvastatin in Experimental Arthritis
   
J.L. Funk, J. Chen, K.J. Downey, R.A. Clark.........1083

Evidence of Silicon Dioxide Crystals in SF of Patients with OA
   
F. Oliviero, P. Frallonardo, L. Peruzzo, et al.........1092

Correlation Between Inflammatory Cells and Sulfated Glycosaminoglycan Concentration in SF of Subjects with Secondary Knee OA
   
R.N. Franco, P.F.A. Cintra Neto, E.R. Pimentel, M. Cohen, G.E.G. Lima, S.M.G. Mattiello-Rosa.........1096

OA and Sleep: The Johnston County Osteoarthritis Project
   
K.D. Allen, J.B. Renner, B. Devellis, C.G. Helmick, J.M. Jordan.........1102

Association Between Crystals and Cartilage Degeneration in the Ankle
   
C. Muehleman, J. Li, T. Aigner, et al.........1108→RELATED ARTICLE

Balneotherapy for OA. A Cochrane Review
   
A. Verhagen, S. Bierma-Zeinstra, J. Lambeck, et al.........1118

Patient Pain and Tissue Trauma During Syringe Procedures: A Randomized Controlled Trial
   
G.R. Moorjani, A.A. Michael, A. Peisajovich, K.S. Park, W.L. Sibbitt Jr, A.D. Bankhurst.........1124

Exercise for FM: A Systematic Review
   
A.J. Busch, C.L. Schachter, T.J. Overend, P.M. Peloso, K.A.R. Barber.........1130

Arthritis in Aboriginal Manitobans: Evidence for a High Burden of Disease
   
C. Barnabe, B. Elias, J. Bartlett, L. Roos, C. Peschken.........1145→RELATED ARTICLE

Pediatric Rheumatology

Global Damage in Systemic JIA: Preliminary Early Predictors
   
R.A.G. Russo, M.M. Katsicas.........1151

IA Corticosteroid Injections of the Temporomandibular Joint in JIA
   
S. Ringold, T.R. Torgerson, M.A. Egbert, C.A. Wallace.........1157

HLA-DRB1 Alleles and Henoch-Schönlein Purpura: Susceptibility and Severity of Disease
   
O. Soylemezoglu, H. Peru, S. Gonen, A. Cetinyurek, N. Buyan.........1165

Images in Rheumatology

Classic Presentation of a Rare Disease: Melorheostosis
 
P. Efthimiou, O. Nasis, L.A. Russell.........1169

Canadian Rheumatology
Association Meeting
Mt. Tremblant, Quebec March 5-8, 2008

Introduction.........1170

Podium Presentations.........1171
 

Posters.........1172
 

Author Index

CorrespondencePDF Correspondence

Duration of Treatment After Eye Involvement in GCA
 
E. Liozon, G. Gondran, K. Ly, V. Loustaud, E. Vidal.........1220

Reply
 
K. Arashvand, W.L. Alexander, B. Dasgupta.........1221

LettersPDF Letters

Cutaneous Granulomas During Infliximab Therapy for SpA
 
A. Economu Dubosc, A-M. Perroud, M. Bagot, et al.........1222

Multiple Autoimmune Diseases in a Young Woman: TB and Splenectomy as Possible Triggering Factors? Another Example of the "Mosaic" of Autoimmunity
 
R.A. Asherson, K. Gunter, D. Daya, Y. Shoenfeld.........1224

TB of the Knee Complicating Seronegative Arthritis
 
S. Arthanari, S. Yusuf, M. Nisar.........1227

Childhood Stroke as the Presentation of Takayasu's Arteritis: Diagnostic Delay Can Cause Catastrophic Complications
 
J. Brunner, D. Armstrong, B.M. Feldman, R. Schneider, S. Benseler.........1228

Longlasting Remissions After Treatment with Rituximab for Autoimmune Myositis
 
E. Feist, T. Dörner, H. Sörensen, G-R. Burmester.........1230

Book ReviewPDF Book Review

Osteoarthritis: A Companion to Rheumatology.........1232
 

Meetings in Rheumatology